AFM15 is a humanized monoclonal antibody inhibitor that targets CD3E. It is useful for researching metabolic and immune system disorders, including type 1 diabetes and inflammatory bowel disease (IBD).
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted
